Ardelyx, Inc.
Status: Publicly traded
Direct answer
Ardelyx, Inc. is publicly traded on NASDAQ under the ticker ARDX.
Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines. The company primarily focuses on addressing gastrointestinal (GI) and cardiorenal conditions, serving patients both domestically in the United States and across international markets. Its flagship product candidate is tenapanor. This drug has successfully completed Phase III clinical...
Can you invest in Ardelyx, Inc.?
Yes. Ardelyx, Inc. trades publicly on NASDAQ as ARDX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ardelyx, Inc.
Detailed equity research is provided by MarketSnap.